Elliogen

Elliogen is a UK-based strategic consultancy founded in 2020, offering specialized advisory services for life sciences companies seeking to enter the French market. The firm operates as an independent intermediary, helping clients navigate regulatory requirements, select appropriate commercial models (such as licensing or co-development), and connect with licensed local partners known as Exploitants. Its expertise spans market intelligence, business development, marketing, and Early Access Program (EAP) strategy, aiming to de-risk market entry and create long-term value for its clients. Unlike a technology or therapeutic developer, Elliogen is a pure-play services firm in the life sciences commercial strategy sector.

Proprietary knowledge network and methodological framework for navigating French pharmaceutical regulatory and commercial landscape, including partner identification and market-entry strategy.

Competes with niche regulatory affairs consultancies, the in-house market access teams of large pharma, and the business development arms of Exploitant companies themselves. Differentiation is based on independence, conflict-free advice, and deep, specialized focus solely on the French market entry challenge.